PEPG PepGen Inc. - Common Stock
NASDAQ · Biotechnology · 在 SEC EDGAR 上查看 ↗ 收盘 十月 2, 2026 10-K/10-Q 八月 6, 2026
$2.28
· % 处于52周区间
· 高于低点
· 至高点
$1.3152周低点
$7.8052周高点
市值
$157M
P/E
-1.1
EPS
$-2.12
PEPG 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$2.28
市值
$157M
P/E
-1.1
EPS
$-2.12
ROE
-82.0%
52周区间
$1–$8
PEPG 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
区间
条形图
柱状图粒度会根据所选周期进行调整 — 将鼠标悬停在图表上可查看柱状图的开盘价/最高价/最低价/收盘价。
10年表现 收入、净利润、利润率和每股收益趋势
EPS$-2.122021-12-31 → 2025-12-31
自由现金流$-82M2022-12-31 → 2025-12-31
估值与比率
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
| 指标 | 5年趋势 | PEPG | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| P/E | -1.15年均值 ≈-2.4 | ≈-2.4 | · | · | |
| P/B (市净率) | 1.15年均值 ≈1.8 | ≈1.8 | 3.4 | 公允价值 | |
| Price / FCF (股价/自由现金流) | -1.95年均值 ≈-3.6 | ≈-3.6 | · | · | |
| Price / Cash Flow (市现率) | -1.95年均值 ≈-3.7 | ≈-3.7 | · | · | |
| Price / Tangible Book (市净率（有形资产）) | 1.15年均值 ≈1.8 | ≈1.8 | · | · |
同行中位数按每项指标的标准化基础计算，可能与本股票显示的TTM/MRQ基础不完全匹配。
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
| 指标 | 5年趋势 | PEPG | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| ROA | -55.2%5年均值 ≈-49.6% | ≈-49.6% | -55.2% | 持平 | |
| ROE | -82.0%5年均值 ≈-64.1% | ≈-64.1% | -47.5% | 弱 | |
| ROIC | -63.5%5年均值 ≈-65.9% | ≈-65.9% | -42.5% | 弱 |
财务健康 债务、流动性、偿付能力 — 资产负债表强度
| 指标 | 5年趋势 | PEPG | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 流动比率 (MRQ) | 13.45年均值 ≈8.9 | ≈8.9 | 8.1 | 流动性强 | |
| Quick Ratio (速动比率) | 11.75年均值 ≈8.7 | ≈8.7 | 6.1 | 流动性强 |
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
此比率组尚无数据
基本面数据不足，尚无法计算此比率组。
资本效率 资产周转率、库存周转率、应收账款周转率
此比率组尚无数据
基本面数据不足，尚无法计算此比率组。
价值 · ≈ 5年均值 · 行业中值 · 相对于中值的评判
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
10.2%
下次报告
十一月 10, 2026
| 期间 | 报告 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|---|
| 2026年6月30日 | 八月 5, 2026 | $-0.26 | $-0.30 | 12.1% |
| 2026年3月31日 | 五月 6, 2026 | $-0.26 | $-0.32 | 18.3% |
| 2025年12月31日 | $-0.27 | $-0.38 | 29.3% | |
| 2025年9月30日 | $-0.52 | $-0.58 | 9.8% | |
| 2025年6月30日 | $-0.70 | $-0.84 | 17.1% | |
| 2025年3月31日 | $-0.92 | $-0.73 | -25.3% |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| R&D Expense | $71M | $76M | $68M | $54M | $19M | |
| SG&A Expense | $23M | $21M | $17M | $14M | $8M | |
| Operating Expenses | $94M | $98M | $85M | $68M | $27M | |
| Operating Income | $-94M | $-98M | $-85M | $-68M | $-27M | |
| Interest Income | $4M | $7M | $6M | $3M | · | |
| Other Non-op | $-11.0K | $-1.0K | $-187.0K | $110.0K | $-172.0K | |
| Pretax Income | $-90M | $-91M | $-79M | $-65M | $-27M | |
| Income Tax | $49.0K | $-617.0K | $73.0K | $4M | $0 | |
| Net Income | $-90M | $-90M | $-79M | $-69M | $-27M | |
| EPS (Basic) | $-2.12 | $-2.85 | $-3.30 | $-4.42 | $-30.27 | |
| EPS (Diluted) | $-2.12 | $-2.85 | $-3.30 | $-4.42 | $-30.27 | |
| Shares (Basic) | 42,221,808 | 31,583,073 | 23,796,000 | 15,639,728 | 901,108 | |
| Shares (Diluted) | 42,221,808 | 31,583,073 | 23,796,000 | 15,639,728 | 901,108 | |
| EBITDA | $-92M | $-96M | $-84M | $-68M | · |
资产负债表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $61M | $49M | $81M | $182M | $133M | |
| Short-term Investments | $88M | $71M | $30M | $0 | · | |
| Prepaid Expense | $3M | $4M | $2M | $4M | $2M | |
| Current Assets | $151M | $124M | $113M | $186M | $140M | |
| PP&E (Net) | $2M | $4M | $5M | $3M | $636.0K | |
| PP&E (Gross) | $6M | $7M | $6M | $4M | $1M | |
| Accum. Depreciation | $4M | $3M | $2M | $389.0K | $430.0K | |
| Other Non-current Assets | $372.0K | $426.0K | $442.0K | $1M | $3M | |
| Total Assets | $174M | $151M | $143M | $217M | $144M | |
| Accounts Payable | $822.0K | $2M | $1M | $1M | $3M | |
| Accrued Liabilities | $9M | $12M | $14M | $12M | $7M | |
| Current Liabilities | $13M | $17M | $18M | $19M | $10M | |
| Capital Leases | $14M | $16M | $17M | $19M | · | |
| Total Liabilities | $26M | $32M | $35M | $38M | $11M | |
| Common Stock | $7.0K | $3.0K | $2.0K | $2.0K | · | |
| Retained Earnings | $-361M | $-271M | $-181M | $-103M | $-34M | |
| AOCI | $11.0K | $23.0K | $34.0K | $-81.0K | $17.0K | |
| Stockholders' Equity | $147M | $119M | $108M | $180M | $-32M | |
| Liabilities + Equity | $174M | $151M | $143M | $217M | $144M | |
| Shares Outstanding | 68,874,944 | 32,619,663 | 23,823,241 | 23,713,196 | 963,588 |
现金流
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| D&A | $1M | $2M | $1M | $500.0K | $200.0K | |
| Stock-based Comp | $11M | $11M | $7M | $5M | $2M | |
| Other Non-cash | $-4M | $-5M | $1M | $5M | · | |
| Operating Cash Flow | $-82M | $-82M | $-69M | $-59M | $-23M | |
| CapEx | $264.0K | $497.0K | $3M | $4M | $500.0K | |
| Investing Cash Flow | $-15M | $-38M | $-32M | $-4M | $-500.0K | |
| Stock Issued | · | $10M | · | $114M | · | |
| Net Stock Activity | · | $10M | · | $114M | · | |
| Financing Cash Flow | $108M | $89M | $-189.0K | $112M | $148M | |
| Net Change in Cash | $11M | $-31M | $-101M | $49M | $125M | |
| Taxes Paid | $82.0K | $71.0K | $3M | · | · | |
| Free Cash Flow | $-82M | $-83M | $-72M | $-63M | · |
盈利能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| ROA | -55.2% | -61.2% | -43.6% | -38.3% | · | |
| ROE | -82.0% | -70.3% | -67.1% | -37.1% | · | |
| ROIC | -63.5% | -81.8% | -78.2% | -40.2% | · |
流动性与偿付能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Current Ratio | 11.9 | 7.4 | 6.4 | 9.9 | · | |
| Quick Ratio | 11.7 | 7.2 | 6.3 | 9.7 | · |
每股
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Book Value / Share | $2.14 | $3.64 | $4.55 | $7.58 | · | |
| Cash Flow / Share | $-1.93 | $-2.61 | $-2.90 | $-3.79 | · | |
| Cash / Share | $0.88 | $1.52 | $3.39 | $7.66 | · | |
| EPS (TTM) | $-2.12 | $-2.85 | $-3.30 | $-4.42 | · |
估值 (TTM)
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Net Income TTM | $-90M | $-90M | $-79M | $-69M | · | |
| Market Cap | $448M | $124M | $162M | $317M | · | |
| P/E | -3.1 | -1.3 | -2.1 | -3.0 | · | |
| P/B | 3.0 | 1.0 | 1.5 | 1.8 | · | |
| P / Tangible Book | 3.0 | 1.0 | 1.5 | 1.8 | · | |
| P / Cash Flow | -5.5 | -1.5 | -2.3 | -5.3 | · | |
| P / FCF | -5.5 | -1.5 | -2.3 | -5.0 | · | |
| Earnings Yield | -32.6% | -75.2% | -48.5% | -33.1% | · |
损益表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $13M | $13M | $14M | $13M | $18M | $25M | $19M | $18M | $25M | $15M | $16M | $21M | $17M | $14M | $16M | $14M | |
| SG&A Expense | $6M | $6M | $6M | $5M | $6M | $6M | $5M | $5M | $5M | $5M | $5M | $4M | $4M | $4M | $4M | $3M | |
| Operating Expenses | $19M | $19M | $20M | $19M | $24M | $31M | $24M | $23M | $30M | $20M | $21M | $25M | $21M | $18M | $20M | $18M | |
| Operating Income | $-19M | $-19M | $-20M | $-19M | $-24M | $-31M | $-24M | $-23M | $-30M | $-20M | $-21M | $-25M | $-21M | $-18M | $-20M | $-18M | |
| Interest Income | $1M | $1M | $1M | $634.0K | $842.0K | $1M | $1M | $2M | $2M | $2M | $1M | $2M | $2M | $2M | $943.0K | $250.0K | |
| Other Non-op | $50.0K | $-56.0K | $-5.0K | $-6.0K | $3.0K | $-3.0K | $26.0K | $-39.0K | $-31.0K | $43.0K | $43.0K | $-88.0K | $-62.0K | $-80.0K | $4.0K | $76.0K | |
| Pretax Income | $-18M | $-18M | $-18M | $-18M | $-23M | $-30M | $-23M | $-21M | $-28M | $-18M | $-19M | $-23M | $-20M | $-16M | $-19M | $-17M | |
| Income Tax | $16.0K | $15.0K | $49.0K | $0 | $0 | $0 | $-617.0K | $0 | $0 | · | · | · | · | · | · | · | |
| Net Income | $-18M | $-18M | $-18M | $-18M | $-23M | $-30M | $-22M | $-21M | $-28M | $-18M | $-19M | $-23M | $-20M | $-16M | $-19M | $-17M | |
| EPS (Basic) | $-0.26 | $-0.26 | $0.02 | $-0.52 | $-0.70 | $-0.92 | $-0.69 | $-0.66 | $-0.87 | $-0.63 | $-0.81 | $-0.98 | $-0.82 | $-0.69 | $-0.79 | $-1.23 | |
| EPS (Diluted) | $-0.26 | $-0.26 | $0.02 | $-0.52 | $-0.70 | $-0.92 | $-0.69 | $-0.66 | $-0.87 | $-0.63 | $-0.81 | $-0.98 | $-0.82 | $-0.69 | $-0.79 | $-1.23 | |
| Shares (Basic) | 69,202,376 | 69,091,100 | · | 34,362,876 | 32,748,646 | 32,674,720 | · | 32,581,542 | 32,469,187 | 28,656,401 | · | 23,790,430 | 23,790,430 | 23,761,915 | 23,562,395 | 14,090,455 | |
| Shares (Diluted) | 69,202,376 | 69,091,100 | · | 34,362,876 | 32,748,646 | 32,674,720 | · | 32,581,542 | 32,469,187 | 28,656,401 | · | 23,790,430 | 23,790,430 | 23,761,915 | 23,562,395 | 14,090,455 | |
| EBITDA | $-19M | $-19M | · | $-18M | $-24M | $-31M | · | $-23M | $-30M | $-19M | · | $-24M | $-21M | $-18M | $-19M | $-18M |
资产负债表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $23M | $42M | $61M | $143M | $35M | $44M | $49M | $42M | $66M | $134M | $81M | $130M | $147M | $165M | $196M | $219M | |
| Short-term Investments | $94M | $90M | $88M | $21M | $40M | $54M | $71M | $97M | $95M | $41M | $30M | · | · | · | · | · | |
| Prepaid Expense | $3M | $2M | $3M | $3M | $3M | $3M | $4M | $4M | $3M | $2M | $2M | $4M | $3M | $3M | $5M | $3M | |
| Current Assets | $120M | $134M | $151M | $166M | $77M | $101M | $124M | $142M | $165M | $178M | $113M | $133M | $150M | $168M | $204M | $226M | |
| PP&E (Net) | $1M | $2M | $2M | $2M | $2M | $4M | $4M | $4M | $4M | $4M | $5M | $5M | $5M | $5M | $3M | $3M | |
| PP&E (Gross) | $6M | $6M | $6M | $6M | $6M | $7M | $7M | $7M | $7M | $6M | $6M | $6M | $6M | $6M | $3M | $3M | |
| Accum. Depreciation | $4M | $4M | $4M | $4M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $1M | $871.0K | $540.0K | $245.0K | $415.0K | |
| Other Non-current Assets | $265.0K | $389.0K | $372.0K | $372.0K | $426.0K | $426.0K | $426.0K | $426.0K | $2M | $2M | $442.0K | $2M | $2M | $1M | $1M | $1M | |
| Total Assets | $141M | $156M | $174M | $190M | $102M | $127M | $151M | $170M | $194M | $207M | $143M | $164M | $182M | $201M | $208M | $231M | |
| Accounts Payable | $1M | $622.0K | $822.0K | $766.0K | $856.0K | $3M | $2M | $6M | $8M | $1M | $1M | $4M | $2M | $1M | $5M | $5M | |
| Accrued Liabilities | $5M | $5M | $9M | $9M | $12M | $15M | $12M | $8M | $11M | $7M | $14M | $14M | $12M | $13M | $11M | $15M | |
| Current Liabilities | $9M | $9M | $13M | $13M | $16M | $20M | $17M | $17M | $22M | $11M | $18M | $21M | $17M | $18M | $16M | $21M | |
| Capital Leases | $13M | $13M | $14M | $14M | $15M | $15M | $16M | $16M | $16M | $17M | $17M | $17M | $18M | $18M | · | · | |
| Total Liabilities | $22M | $22M | $26M | $27M | $31M | $36M | $32M | $33M | $38M | $28M | $35M | $38M | $35M | $36M | $16M | $21M | |
| Common Stock | $7.0K | $7.0K | $7.0K | $7.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | |
| Retained Earnings | $-397M | $-379M | $-361M | $-343M | $-325M | $-302M | $-271M | $-249M | $-228M | $-200M | $-181M | $-162M | $-139M | $-119M | $-88M | $-69M | |
| AOCI | $-117.0K | $-59.0K | $11.0K | $-25.0K | $-43.0K | $-22.0K | $23.0K | $91.0K | $-75.0K | $-37.0K | $34.0K | $-57.0K | $13.0K | $-28.0K | $-130.0K | $-99.0K | |
| Stockholders' Equity | $120M | $134M | $147M | $163M | $71M | $92M | $119M | $137M | $155M | $179M | $108M | $126M | $147M | $165M | $193M | $210M | |
| Liabilities + Equity | $141M | $156M | $174M | $190M | $102M | $127M | $151M | $170M | $194M | $207M | $143M | $164M | $182M | $201M | $208M | $231M | |
| Shares Outstanding | · | · | 68,874,944 | · | · | · | 32,619,663 | · | · | · | 23,823,241 | · | · | · | · | · |
现金流
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $300.0K | $300.0K | $400.0K | $300.0K | $300.0K | $400.0K | $300.0K | $400.0K | $400.0K | $400.0K | $400.0K | $300.0K | $300.0K | $200.0K | $100.0K | $100.0K | |
| Stock-based Comp | $3M | $3M | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | |
| Other Non-cash | · | $-4M | · | · | · | $3M | · | · | · | $-7M | · | · | · | $-651.0K | · | · | |
| Operating Cash Flow | $-16M | $-18M | $-16M | $-19M | $-24M | $-23M | $-19M | $-24M | $-16M | $-23M | $-19M | $-16M | $-17M | $-15M | $-21M | $-13M | |
| CapEx | $30.0K | $0 | $-1.0K | $97.0K | $43.0K | $125.0K | $228.0K | $185.0K | $31.0K | $53.0K | $184.0K | $225.0K | $1M | $1M | $430.0K | $609.0K | |
| Investing Cash Flow | $-4M | $-1M | $-66M | $19M | $15M | $17M | $27M | $-133.0K | $-53M | $-11M | $-30M | $-225.0K | $-1M | $-1M | $-430.0K | $-609.0K | |
| Stock Issued | $0 | $2M | · | $0 | $0 | $0 | $0 | $0 | $0 | $10M | · | · | · | · | $0 | · | |
| Net Stock Activity | · | $2M | · | · | · | $0 | · | · | · | $10M | · | · | · | · | · | · | |
| Financing Cash Flow | $-65.0K | $2M | $-171.0K | $108M | $98.0K | $0 | $128.0K | $327.0K | $1M | $87M | $26.0K | $-534.0K | $-19.0K | $130.0K | $-1M | $113M | |
| Net Change in Cash | $-19M | $-18M | $-82M | $108M | $-9M | $-6M | $7M | $-24M | $-68M | $53M | $-49M | $-17M | $-18M | $-16M | $-23M | $100M | |
| Taxes Paid | $49.0K | $0 | $-4.0K | $0 | $0 | $86.0K | $0 | $0 | $71.0K | $0 | · | · | · | · | · | · | |
| Free Cash Flow | · | $-18M | · | · | · | $-23M | · | · | · | $-23M | · | · | · | $-17M | · | · |
盈利能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -14.6% | -12.5% | · | -10.0% | -15.6% | -18.1% | · | -12.8% | -15.1% | -8.8% | · | -12.5% | -9.5% | -9.8% | -17.8% | -15.0% | |
| ROE | -18.7% | -15.7% | · | -12.0% | -20.4% | -22.3% | · | -16.2% | -18.7% | -10.5% | · | -14.6% | -10.9% | -28.3% | -19.3% | -16.5% | |
| ROIC | -15.9% | -14.1% | · | -11.4% | -33.6% | · | · | · | · | · | · | · | · | · | · | · |
流动性与偿付能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 13.4 | 15.0 | · | 13.1 | 4.7 | 4.9 | · | 8.5 | 7.5 | 15.8 | · | 6.4 | 8.9 | 9.3 | 13.2 | 11.0 | |
| Quick Ratio | 13.0 | 14.8 | · | 12.9 | 4.6 | 4.8 | · | 8.3 | 7.3 | 15.6 | · | 6.2 | 8.7 | 9.2 | 12.6 | 10.6 |
每股
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow / Share | · | $-0.27 | · | · | · | $-0.70 | · | · | · | $-0.79 | · | · | · | $-0.65 | · | · | |
| EPS (TTM) | $-1.02 | $-1.46 | · | $-2.83 | $-2.97 | $-3.14 | · | $-2.97 | $-3.29 | $-3.24 | · | · | · | · | $-28.71 | $-36.99 |
估值 (TTM)
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-72M | $-77M | · | $-94M | $-97M | $-102M | · | $-87M | $-89M | $-80M | · | · | · | · | $-61M | $-51M | |
| P/E | -1.8 | -1.2 | · | -1.6 | -0.4 | -0.4 | · | -2.9 | -4.9 | -4.5 | · | · | · | · | -0.3 | -0.3 | |
| Earnings Yield | -56.7% | -82.5% | · | -61.3% | -267.6% | -223.5% | · | -34.7% | -20.6% | -22.0% | · | · | · | · | -316.2% | -372.5% |
最近期在左侧 · 空值显示为 ·
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 净收入 | $-90M | $-90M | $-79M | $-69M | $-27M |
| 稀释后每股收益 (EPS) | $-2.12 | $-2.85 | $-3.30 | $-4.42 | $-30.27 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 流动比率 | 11.9 | 7.4 | 6.4 | 9.9 | · |
| 速动比率 | 11.7 | 7.2 | 6.3 | 9.7 | · |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 自由现金流 | $-82M | $-83M | $-72M | $-63M | · |
机构持有人 (13F) 79 家申报者 · $107.0M 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
持有人
79
持有价值
$107.0M
新仓位
6
已退出持仓
28
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 6 (-25 与上一季度对比) | 28 (+10 与上一季度对比) | 21 (-8 与上一季度对比) | 28 (+1 与上一季度对比) | -4.9M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | $36116181 | 20064545 | 33.77% | 股份 |
| VANGUARD GROUP INC | $14405549 | 2212834 | 13.47% | 股份 |
| Commodore Capital LP | $8055000 | 4475000 | 7.53% | 股份 |
| VIKING GLOBAL INVESTORS LP | $6268381 | 3482434 | 5.86% | 股份 |
| Laurion Capital Management LP | $4951539 | 2750855 | 4.63% | 股份 |
| ADAR1 Capital Management, LLC | $4663953 | 2591085 | 4.36% | 股份 |
| Vivo Capital, LLC | $4185000 | 2325000 | 3.91% | 股份 |
| VANGUARD CAPITAL MANAGEMENT LLC | $3484656 | 1935920 | 3.26% | 股份 |
| MILLENNIUM MANAGEMENT LLC | $3216177 | 1786765 | 3.01% | 股份 |
| RENAISSANCE TECHNOLOGIES LLC | $2736443 | 1520246 | 2.56% | 股份 |
| BlackRock, Inc. | $2347672 | 1304262 | 2.20% | 股份 |
| MARSHALL WACE, LLP | $1560585 | 866992 | 1.46% | 股份 |
| CITADEL ADVISORS LLC | $1185086 | 658381 | 1.11% | 股份 |
| AWM Investment Company, Inc. | $1080000 | 600000 | 1.01% | 股份 |
| MONIMUS CAPITAL MANAGEMENT, LP | $1057838 | 587688 | 0.99% | 股份 |
| Squarepoint Ops LLC | $952349 | 529083 | 0.89% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $942806 | 523473 | 0.88% | 股份 |
| Creek Drive Management Group LLC | $810000 | 450000 | 0.76% | 股份 |
| Ikarian Capital, LLC | $804897 | 447165 | 0.75% | 股份 |
| DIADEMA PARTNERS LP | $671911 | 373284 | 0.63% | 股份 |
| BOOTHBAY FUND MANAGEMENT, LLC | $659054 | 366141 | 0.62% | 股份 |
| Rosalind Advisors, Inc. | $630000 | 350000 | 0.59% | 股份 |
| Driehaus Capital Management LLC | $503836 | 279909 | 0.47% | 股份 |
| Boxer Capital Management, LLC | $491206 | 272892 | 0.46% | 股份 |
| VANGUARD FIDUCIARY TRUST CO | $470657 | 261476 | 0.44% | 股份 |
| XTX Topco Ltd | $441625 | 245347 | 0.41% | 股份 |
| STATE STREET CORP | $412902 | 229390 | 0.39% | 股份 |
| Artia Global Partners LP | $369583 | 205324 | 0.35% | 股份 |
| JANE STREET GROUP, LLC | $310342 | 172412 | 0.29% | 股份 |
| GOLDMAN SACHS GROUP INC | $302598 | 168110 | 0.28% | 股份 |
| Connor, Clark & Lunn Investment Management Ltd. | $201728 | 112071 | 0.19% | 股份 |
| UBS Group AG | $199211 | 110673 | 0.19% | 股份 |
| NORTHERN TRUST CORP | $177728 | 98738 | 0.17% | 股份 |
| Qube Research & Technologies Ltd | $177446 | 98581 | 0.17% | 股份 |
| RBF Capital, LLC | $171076 | 95042 | 0.16% | 股份 |
| Persistent Asset Partners Ltd | $171005 | 95003 | 0.16% | 股份 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $168660 | 93700 | 0.16% | 股份 |
| Cubist Systematic Strategies, LLC | $141695 | 30670 | 0.13% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $135749 | 75416 | 0.13% | 股份 |
| TWO SIGMA ADVISERS, LP | $135447 | 20806 | 0.13% | 股份 |
| Rangeley Capital, LLC | $126000 | 70000 | 0.12% | 股份 |
| Verdad Advisers, LP | $120384 | 66880 | 0.11% | 股份 |
| TWO SIGMA INVESTMENTS, LP | $119282 | 66268 | 0.11% | 股份 |
| DIMENSIONAL FUND ADVISORS LP | $97319 | 54113 | 0.09% | 股份 |
| MORGAN STANLEY | $87916 | 48842 | 0.08% | 股份 |
| AMERICAN CENTURY COMPANIES INC | $76682 | 42601 | 0.07% | 股份 |
| Quadrature Capital Ltd | $73685 | 40936 | 0.07% | 股份 |
| Point72 Asset Management, L.P. | $71496 | 39720 | 0.07% | 股份 |
| Rathbones Group PLC | $57605 | 32003 | 0.05% | 股份 |
| READYSTATE ASSET MANAGEMENT LP | $51082 | 28379 | 0.05% | 股份 |
激进投资者及 5%+ 股东 1 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权，意图影响发行人（激进股东持股、董事会活动、并购）。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, RA Capital Healthcare Fund, L.P. ×5 申报 | 2025年9月30日 | 29.20% | 修订 | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
公司内部人士 19 位内幕人士 · 10 位高管 · 9 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| James G Mcarthur | President and CEO | 2026年3月4日 S | 296326 | 0 | 2 | $-32875 |
| Noel Donnelly | Chief Financial Officer | 2026年3月4日 S | 111603 | 0 | 2 | $-12988 |
| Kasra Kasraian | Chief Technical Officer | 2026年5月21日 S | 50074 | 0 | 1 | $-1739 |
| Paul Streck | EVP, Head of R&D | 2026年3月4日 S | 76226 | 0 | 2 | $-11709 |
| Joseph Vittiglio | Chief Business & Legal Officer | 2026年3月1日 A | 65717 | 0 | 0 | $0 |
| Mary Beth Delena | General Counsel | 2025年3月3日 A | 14968 | 0 | 0 | $0 |
| Michelle L Mellion | Chief Medical Officer | 2024年7月25日 M | 0 | 0 | 0 | $0 |
| Niels Svenstrup | SVP, Chem. Mfg & Controls | 2024年5月17日 S | 0 | 0 | 0 | $0 |
| Jaya Goyal | EVP, Res. & Preclin. Dev. | 2023年3月24日 M | 0 | 0 | 0 | $0 |
| Sonia Bracegirdle | Sr. VP Strategy & Operations | 2022年5月6日 A | · | 0 | 0 | $0 |
| Lisa Wyman | 董事 | 2026年6月18日 A | · | 0 | 0 | $0 |
| Howard Mayer | 董事 | 2026年6月18日 A | · | 0 | 0 | $0 |
| Joshua Resnick | 董事 | 2026年6月18日 A | · | 0 | 0 | $0 |
| Habib J Dable | 董事 | 2026年6月18日 A | · | 0 | 0 | $0 |
| Laurie Keating | 董事 | 2026年6月18日 A | 4166 | 0 | 0 | $0 |
| Mitchell H. Finer | 董事 | 2026年6月18日 A | · | 0 | 0 | $0 |
| Heidi Henson | 董事 | 2026年6月18日 A | · | 0 | 0 | $0 |
| Christopher Ashton | 董事 | 2024年6月20日 A | · | 0 | 0 | $0 |
| Oxford Sciences Innovation plc | · | 2025年9月30日 P | 4955388 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
ETF持仓 由 6 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| IBRN · iShares Trust | 0.19% | 4634 SH | 2026年9月11日 | 每日 |
| IWC · iShares Trust | 0.03% | 139850 SH | 2026年9月11日 | 每日 |
| IBB · iShares Trust | 0.01% | 477680 SH | 2026年9月11日 | 每日 |
| IBBQ · Invesco Exchange-Traded Fund Trus... | 0.01% | 4899 SH | 2026年10月2日 | 每日 |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 480909 SH | 2026年8月19日 | 每日 |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 1408449 SH | 2026年8月19日 | 每日 |
PEPG 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
评级 · 14 位分析师
买入
中位数目标
$10.50
+360.5%
7 50.0%
强烈买入
5 35.7%
买入
1 7.1%
持有
1 7.1%
卖出
0 0.0%
强烈卖出
12个月价格目标
8 位分析师 · 2026-09-30平均目标 $10.19 +346.8%
← 低于所有目标
当前价格 $2.28
最低$2.50
平均值$10.19
最高$20.00
同行比较（GICS 子行业） 关键指标与行业同行对比
财年依据，价格截至各公司上一个财年末收盘价。
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| PEPG | $448M | -3.1 | · | · | -82.0% | · |
| ALXO | $61M | -0.6 | · | · | -225.0% | · |
| ORGO | $658M | 34.5 | 17.0% | 6.6% | 13.9% | · |
| AVXL | · | -16.5 | -36.1% | -991.4% | · | · |
| VYGR | $232M | -1.9 | -49.5% | -296.5% | -54.4% | · |
| TARA | $286M | -4.0 | · | · | -33.7% | · |
| NERV | $174M | -0.1 | · | · | 339.5% | · |
| CMPX | $958M | · | · | · | -45.9% | · |
| NBP | $1.06B | -19.0 | · | · | -21.4% | · |
| TNXP | $200M | -1.1 | 29.8% | -946.2% | -60.0% | · |
| ABOS | $128M | -1.1 | · | · | -129.4% | · |
我的指标 您的个人关注列表 — 来自完整基本面的选定行
选择对您重要的指标 — 点击上方完整基本面中任意行的 + 号。
您的选择已保存，并会跟随您浏览所有股票。
来源：SEC 10-Q 于 八月 6, 2026 申报